Celltrion
068270.KS
#829
Rank
โ‚น2.514 T
Marketcap
โ‚น11,179
Share price
0.38%
Change (1 day)
12.53%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น90.55

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น96.13. In 2023 the company made an earnings per share (EPS) of โ‚น248.63 a decrease over its 2022 EPS that were of โ‚น253.91.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น90.55
2023โ‚น248.63-2.08%
2022โ‚น253.91-11.72%
2021โ‚น287.622.03%
2020โ‚น281.8982.8%
2019โ‚น154.2018.31%
2018โ‚น130.34-36.33%
2017โ‚น204.72161.25%
2016โ‚น78.362.86%
2015โ‚น76.1817.84%
2014โ‚น64.655.87%
2013โ‚น61.06-70.85%
2012โ‚น209.48134.09%
2011โ‚น89.4943.59%
2010โ‚น62.3274.49%
2009โ‚น35.72317.8%
2008โ‚น8.55-71.7%
2007โ‚น30.21